Maciej Mrugala

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17

Central Nervous System Cancers

Burt Nabors, Mario Ammirati, Philip J. Bierman et al. · Journal of the National Comprehensive Cancer Network · 2013 · 250 citations · Full text

Medicine, Neurology, Oncology +15

Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy

Jennifer E. Adair, Brian C. Beard, Grant D. Trobridge et al. · Science Translational Medicine · 2012 · 99 citations

Medicine, Biotechnology, Oncology +15

Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression

Maxwell L. Neal, Andrew D. Trister, Sunyoung Ahn et al. · Cancer Research · 2013 · 73 citations · Full text

Medicine, Oncology, Radiology +17

Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer

Maciej Mrugala, Bryan Kim, Akanksha Sharma et al. · Clinical Breast Cancer · 2019 · 42 citations

Medicine, Oncology, Pharmacology +17